Abstract
Economic analysis of health care, and of clinical medicine in particular, has attracted increasing attention in recent years. In part, this may reflect a growing perception that health care spending is reaching inordinate levels. Most people would agree with the view that investments in maintaining, promoting, or restoring health care are well spent. However, finite health care resources confront potentially limitless demands and, at some point, choices must be made. Economic analysis informs the process of making such choices, both among different health care technologies and between health care and other forms of investment and consumption.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.D. Nettelman, R.B. Jones, S.D. Roberts, P. Katz, E. Washington, R.S. Dittus, T.S. Quinn, Cost-effectiveness of culturing for Chlamydia trachomatis, Ann. Intern. Med. 105:189–96 (1986).
C. Bombardier, J. Eisenberg, Looking into the crystal ball: Can we estimate the lifetime cost of rheumatoid arthritis?, J. Rheumatol. 12:201–204 (1984).
A. Velez-Gil, D. Wilson, R. Nel Peleaz, A simplified system for surgical operation. The economics of treating hernia, Surgery 77:391–402 (1975).
G. Torrance, Measurement of health state utilities for economic appraisal — a review, J Health Econ. 5:1–30 (1986).
J. Eisenberg, D. Kitz, Savings from outpatient antibiotic therapy for osteomyelitis, Economic analysis of a therapeutic strategy, JAMA 225:1584–8 (1986).
J.M. Eisenberg, H. Koffer, S.A. Finkler, Economics analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral Cephalosporin, Rev. Infect. Dis. 6:S909–23 (1984).
W.F. McGhan, C.R. Rowland, J.L. Bootman, Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services, Am. J. Hosp. Pharm. 36:133–140 (1979).
J. Paxinos, R.J. Hammel, W.L. Fritz, Contamination rates and costs associated with the use of four intermittent intravenous infusion systems, Am. J. Hosp. Pharm. 36:1497–503 (1978).
S. Finkler, Cost finding for high-technology, high-cost services: current practices and a possible alternative, Health Care Manage. Rev. 5:17–29 (1980).
S.V. Williams, S.A. Finkler, C. Murphy, J.M. Eisenberg, Improved cost allocation in case-mix accounting, Med. Care 20:450–9 (1982).
T.W. Granneman, R.S. Brown, M.V. Pauly, Estimating hospital costs: a multiple output analysis, J. Health Econ. 5:107–27 (1986).
M.S. Thompson, J.L. Read, M. Liang, Feasibility of willingness-to-pay measurement in chronic arthritis, Med. Decis. Making 4:195–215 (1984).
M. Thompson, Willingness to pay and accept risks to cure chronic disease, Am. J. Public Health 76:392–96 (1986).
R.C. Lind, A primer on the major issues relating to the discount rate for evaluating national energy options, in: “Discounting for time and risk in energy policy,” R.C. Lind, et. al., eds., Resources for the Future, Inc., Washington, D.C. 21-94 (1982).
Further Reading
A.S. Detsky, and I.G. Naglie, A clinician’s guide to cost-effectiveness analysis, Ann Intern. Med. 113:147–154 (1990).
M.F. Drummond, G.L. Stoddart, and G.W. Torrance, “Methods for the economic evaluation of health programmes,” Oxford: Oxford University Press, (1987).
J.M. Eisenberg, H. Glick, and H. Koffer, Pharmacoeconomics: economic evaluation of Pharmaceuticals, in: “Pharmacoepidemiology,” B.L. Strom, ed., Churchill, Livingstone, N.Y., 325-350 (1989).
K.E. Warner, and B.R. Luce, “Cost-benefit and cost-effectiveness analysis in health care: principles, practice, and potential,” Health Administration Press, Ann Arbor, MI, (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Glick, H., Kington, R. (1992). Pharmacoeconomics: Principles and Basic Techniques of Economic Analysis. In: Strom, B.L., Velo, G. (eds) Drug Epidemiology and Post-Marketing Surveillance. NATO ASI Series, vol 224. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2587-9_15
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2587-9_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2589-3
Online ISBN: 978-1-4899-2587-9
eBook Packages: Springer Book Archive